Supramolecular Reactivation of Quenched Silicon Naphthalocyanine for NIR-II Fluorescence-Guided Type I/II Photodynamic Monotherapy
- 25 June 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (26) , 36534-36546
Abstract
Silicon 2,3-naphthalocyanine bis(trihexylsilyloxide) (SiNc) possesses intense near-infrared absorption, promising NIR-II emission, and a high reactive oxygen species quantum yield in its monomeric state. However, its potential as a NIR-II fluorescent photosensitizer has been long hindered by aggregation-caused quenching in aqueous environments. Herein, we report a supramolecular engineering strategy to overcome this limitation by precisely tuning the molecular packing of SiNc within a biocompatible DSPE-PEG2000 matrix. Through systematic optimization of the dye-to-matrix ratio, initial dye concentration, and solvent composition, we obtain optimized nanoparticles (SiNc NPs) that effectively disrupt tight π-π stacking. Compared to severely quenched control nanoparticles (Ctrl-NPs), SiNc NPs exhibit a 3-fold enhancement in fluorescence quantum yield (4.2% vs 1.4%), alongside 17.7-fold and 8.7-fold increases in 1O2 (ΦΔ = 10.6% vs 0.6%) and O2•- generation, respectively. Consequently, SiNc NPs deliver potent NIR-II fluorescence-guided photodynamic efficacy in vivo. Following a single low-dose intravenous injection and one session of 781 nm laser irradiation, SiNc NPs achieve near-complete 4T1 tumor eradication, showing improved efficacy compared to both a clinical photosensitizer (Ce6) and Ctrl-NPs under the tested conditions. This work establishes a programmable supramolecular paradigm for reactivating highly quenched, aggregation-prone chromophores, offering a practical alternative to complex de novo synthesis in the pursuit of high-performance NIR-II fluorescent photosensitizers capable of effective photodynamic monotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (22275087)
This publication has 53 references indexed in Scilit:
- A NIR‐II‐Emissive Organic Nanomedicine with Biomimetic Engineering for High‐Contrast Targeted Bioimaging and Multiple Phototherapies of Pancreatic TumorsAdvanced Functional Materials, 2024
- High‐Performance NIR‐II Fluorescent Type I/II Photosensitizer Enabling Augmented Mild Photothermal Therapy of Tumors by Disrupting Heat Shock ProteinsAdvanced Healthcare Materials, 2024
- NIR‐II Excitable Semiconducting Polymers with AIE Characteristics for Fluorescence‐Photoacoustic Imaging‐Guided Synergistic PhototherapyAdvanced Functional Materials, 2024
- Heptamethine Cyanine Dyes with Ultra‐Efficient Excited‐State Nonradiative Decay for Synergistic Photothermal ImmunotherapyAdvanced Functional Materials, 2023
- An NIR‐II‐Emissive Photosensitizer for Hypoxia‐Tolerant Photodynamic TheranosticsAdvanced Materials, 2020
- Zwitterionic AIEgens: Rational Molecular Design for NIR‐II Fluorescence Imaging‐Guided Synergistic PhototherapyAdvanced Functional Materials, 2020
- An All‐Round Athlete on the Track of Phototheranostics: Subtly Regulating the Balance between Radiative and Nonradiative Decays for Multimodal Imaging‐Guided Synergistic TherapyAdvanced Materials, 2020
- All‐in‐One Phototheranostics: Single Laser Triggers NIR‐II Fluorescence/Photoacoustic Imaging Guided Photothermal/Photodynamic/Chemo Combination TherapyAdvanced Functional Materials, 2019
- Repurposing Cyanine NIR‐I Dyes Accelerates Clinical Translation of Near‐Infrared‐II (NIR‐II) BioimagingAdvanced Materials, 2018
- Real‐Time and High‐Resolution Bioimaging with Bright Aggregation‐Induced Emission Dots in Short‐Wave Infrared RegionAdvanced Materials, 2018